What Is Microdose GLP-1 — And Is It Right for You?
By Diane Lietz, MSN, APRN, FNP-C | VGM Health | 7 min read
You tried the medication everyone's talking about. Maybe you felt nauseated for weeks. Maybe it suppressed your appetite so completely you stopped eating enough — and lost muscle instead of fat. Maybe you just couldn't tolerate it and gave up.
What nobody told you is that the dose matters as much as the drug. And most providers start everyone in the same dose, regardless of who you are.
I don't do that.
I've held that belief through every stage of my career — as a bedside nurse, in practice, and now at VGM Health. Thirty-seven years in, that hasn't changed. Microdose GLP-1 is built entirely around that philosophy.
First — What Does GLP-1 Actually Do?
GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces. It plays a role in regulating appetite, blood sugar, insulin secretion, digestion, and even inflammation. GLP-1 receptor agonist medications work by amplifying those natural signals — helping your body do what it was designed to do, just more effectively.
What most people don't realize is that GLP-1 medications aren't just appetite suppressants. They work across multiple body systems simultaneously:
- Appetite and craving control — reducing the constant noise of hunger and food fixation
- Insulin stabilization — which directly affects hormone balance and fat storage
- Inflammation reduction — through downregulation of pro-inflammatory cytokines
- Gut motility — slowing digestion in a way that supports satiety and blood sugar stability
- Metabolic function — supporting the reduction of visceral fat, the dangerous fat stored around your organs. Studies have also shown meaningful reductions in liver fat, making GLP-1 medications one of the few effective interventions for non-alcoholic fatty liver disease (NAFLD)
This is why GLP-1 medications have shown benefits far beyond weight loss — including cardiovascular protection and improvements in metabolic syndrome.
Metabolism and Hormones Are Not Separate Conversations
One thing I often see in my metabolic patients: weight loss stalls or slows when hormones are out of balance. For women, estrogen and progesterone fluctuations directly affect fat storage and metabolism. For men, low testosterone makes it harder to lose fat and maintain muscle — even on a GLP-1 program. When we work together, I look at the whole picture. Sometimes optimizing metabolism means looking beyond metabolism.
So What Is Microdosing?
Microdosing simply means starting at a dose lower than the standard FDA-approved starting dose — and staying there as long as it's working for you.
Here's something most people don't know: the brand-name GLP-1 pens — Wegovy, Zepbound — are pre-filled at fixed doses. You can't adjust them below the manufacturer's starting point. That means every patient starts at the same place, regardless of their body, their history, or their sensitivity.
Microdosing requires a compounded formulation, which allows me to prescribe a truly individualized dose — one calibrated specifically to you.
A Note on the Evidence
Microdosing GLP-1 is not yet a formally studied protocol — it's a clinical approach rooted in established GLP-1 pharmacology and the principle that individualized dosing always outperforms one-size-fits-all medicine. The underlying science on how GLP-1 medications affect appetite, insulin, inflammation, and fat metabolism is robust and well-documented. The microdose application of that science is clinical judgment — mine, applied to your specific situation.
I will always tell you what's evidence-based and what's clinical experience. You deserve to know the difference.
Who Is Microdose GLP-1 For?
Microdosing is not for everyone. But it can be exactly right for the right person.
You might be a good candidate if:
- You've heard about GLP-1 side effects — nausea, fatigue, digestive upset — and are hesitant to start
- You have a sensitive gut or a history of GI issues and want to start low and slow
- You don't need aggressive weight loss — you need the edge taken off your appetite while you build better habits
- You've lost weight too fast before and know it came at the cost of muscle
- You want a tool, not a crutch — something that supports your effort without doing all the work for you
Why I Believe in the "Low and Slow" Approach
One thing I see too often with standard GLP-1 dosing is that the appetite suppression becomes so powerful that patients stop eating enough — and when that happens, the body doesn't just lose fat. It loses muscle.
Muscle is your metabolic engine. Losing it makes long-term weight maintenance harder, not easier.
With microdosing, the goal is different. We're taking the edge off appetite — enough that you can make better choices, tune in to your hunger signals, and learn how to eat, move, sleep, and hydrate in a way that actually sustains results. I've seen it help people break their soda habit, stop reaching for sweets at night, and finally feel in control of cravings without feeling like they're on a medication that's running their life.
It also works beautifully for people with gut health concerns. Starting at a very low dose and titrating gradually — only if and as needed — gives the body time to adapt. In my experience, this approach dramatically reduces side effects and improves tolerability.
The Ideal Metabolism Patient — In My Opinion
The person who tends to do best in my metabolic programs is someone who has genuinely tried. They're not looking for a shortcut. They've followed relatively healthy diets, they've heard "eat less, move more" a hundred times, and they know something isn't adding up. Often they're dealing with visceral fat — the stubborn fat around the midsection that doesn't respond to conventional effort and drives metabolic syndrome.
These are people whose metabolism is working against them, not with them. GLP-1 medications — at the right dose — help level that playing field.
Semaglutide vs. Tirzepatide for Microdosing
Both semaglutide and tirzepatide can be used in a microdose protocol. I personally tend to favor tirzepatide because it works on two receptor pathways (GLP-1 and GIP), which can produce broader metabolic benefits. That said, semaglutide is often more affordable and is an excellent option for many patients. The right choice depends on your individual health picture, your goals, and your budget — and that's a conversation we have together.
This Is Personalized Medicine
What I want you to take away from this is simple: there is no one-size-fits-all dose, no one-size-fits-all medication, and no one-size-fits-all program. Microdose GLP-1 is one tool in a broader approach to metabolic health — and it's a tool I'm proud to offer because I've seen what it can do for the right patient.
If you've been curious about GLP-1 medications but hesitant to jump in, this might be the conversation worth having.
Ready to find out if microdose GLP-1 is right for you? Start with a free 5-minute consult — no obligation, no pressure. Diane reviews every submission personally. Start Your Free Quick Consult HERE
References
- Liao C, Liang X, Zhang X, Li Y, et al. The effects of GLP-1 receptor agonists on visceral fat and liver ectopic fat in an adult population with or without diabetes and nonalcoholic fatty liver disease: A systematic review and meta-analysis. PLOS One. 2023;18(8):e0289616.
- Alharbi SH. Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications. Therapeutic Advances in Endocrinology and Metabolism. 2024.
- GLP-1 receptor agonists and inflammatory pathway modulation: Dual targeting of metabolic and immune dysfunction in insulin resistance. Biochemical and Biophysical Research Communications. 2025.
The references above support the mechanisms described in this post. As noted, microdose GLP-1 protocols specifically are not yet formally studied — the citations above reflect established research on GLP-1 receptor agonists at standard doses.
Diane Lietz, MSN, APRN, FNP-C is the founder and sole clinician at VGM Health in Springfield, IL. She offers in-person and telehealth care throughout Illinois. All prescribing is conducted through DrWell, a LegitScript-certified platform, using 503A/503B compliant compounding pharmacies.